Is Buying Inogen, Inc. (INGN) Here a Winning Strategy?

April 16, 2018 - By Ellis Scott

Inogen, Inc. (NASDAQ:INGN) Logo

Investors sentiment decreased to 1.18 in Q4 2017. Its down 0.02, from 1.2 in 2017Q3. It dived, as 19 investors sold Inogen, Inc. shares while 68 reduced holdings. 37 funds opened positions while 66 raised stakes. 20.27 million shares or 1.65% less from 20.61 million shares in 2017Q3 were reported.
Brown Cap Management Ltd Liability Co invested in 3.27% or 2.26M shares. Ubs Asset Mngmt Americas invested in 9,015 shares. Moreover, Proshare Advsrs Ltd Llc has 0% invested in Inogen, Inc. (NASDAQ:INGN). Goldman Sachs Grp reported 83,318 shares stake. Tirschwell And Loewy Incorporated accumulated 164,055 shares. Partner Fund Mngmt Lp invested 0.26% in Inogen, Inc. (NASDAQ:INGN). Partner Inv Management L P holds 0.16% of its portfolio in Inogen, Inc. (NASDAQ:INGN) for 1,175 shares. Sector Pension Investment Board has 0.01% invested in Inogen, Inc. (NASDAQ:INGN) for 10,713 shares. Riverhead Mngmt Limited Co holds 1,035 shares or 0.01% of its portfolio. 25,688 are owned by Timpani Capital Ltd Liability Company. 45,527 were reported by Next Century Growth Investors Ltd Liability Corporation. Moreover, Jpmorgan Chase & has 0% invested in Inogen, Inc. (NASDAQ:INGN) for 53,102 shares. Pinebridge Invs L P holds 0.02% or 6,295 shares. Barclays Plc holds 2,970 shares or 0% of its portfolio. Moreover, State Bank Of America De has 0% invested in Inogen, Inc. (NASDAQ:INGN).

The stock of Inogen, Inc. (NASDAQ:INGN) reached all time high today, Apr, 16 and still has $152.21 target or 9.00 % above today’s $139.64 share price. This indicates more upside for the $2.96B company. This technical setup was reported by Barchart.com. If the $152.21 PT is reached, the company will be worth $266.58M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 0.52% or $0.72 during the last trading session, reaching $139.64. About 66,389 shares traded. Inogen, Inc. (NASDAQ:INGN) has risen 59.63% since April 16, 2017 and is uptrending. It has outperformed by 48.08% the S&P500.

Analysts await Inogen, Inc. (NASDAQ:INGN) to report earnings on May, 8. They expect $0.27 EPS, 0.00 % or $0.00 from last year’s $0.27 per share. INGN’s profit will be $5.73M for 129.30 P/E if the $0.27 EPS becomes a reality. After $0.31 actual EPS reported by Inogen, Inc. for the previous quarter, Wall Street now forecasts -12.90 % negative EPS growth.

Inogen, Inc. (NASDAQ:INGN) Ratings Coverage

Among 4 analysts covering Inogen (NASDAQ:INGN), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Inogen had 6 analyst reports since November 8, 2017 according to SRatingsIntel. The stock of Inogen, Inc. (NASDAQ:INGN) has “Buy” rating given on Tuesday, February 20 by Piper Jaffray. The stock of Inogen, Inc. (NASDAQ:INGN) has “Overweight” rating given on Tuesday, February 20 by PiperJaffray. The firm has “Buy” rating by Needham given on Wednesday, February 28. The rating was maintained by Needham on Friday, April 13 with “Buy”. As per Wednesday, November 8, the company rating was maintained by Needham. The stock of Inogen, Inc. (NASDAQ:INGN) earned “Buy” rating by Leerink Swann on Wednesday, November 8.

Inogen, Inc., a medical technology company, primarily develops, makes, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company has market cap of $2.96 billion. The company's oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It has a 145.46 P/E ratio. It offers Inogen One systems, which are portable devices that concentrate the air around the patients to provide a single source of supplemental oxygen; and Inogen At Home stationary oxygen concentrators, as well as related accessories.

Inogen, Inc. (NASDAQ:INGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.